August 15, 2017
Sterility concerns have prompted SCA Pharmaceuticals to recall cefazolin 3 g added to 100 mL 0.9% sodium chloride, total approximate volume 115 mL, single-dose container bags (NDC 70004-0524-32), according to the August 2, 2017, US Food and Drug Administration (FDA) Enforcement Report.
The recalled bags are from lot 20170707@26, which has a beyond-use date of August 21, 2017. The bags were distributed throughout the United States and have the potential to leak.
Adverse Events Common, Often Avoidable in Hospitalized Patients on Antibiotics
Ongoing Antibiotic Prophylaxis Helps Prevent Cellulitis Recurrence
SCA Pharmaceuticals announced the recall July 14, 2017. On July 25, 2017, the FDA designated it Class II. The designation indicates exposure could cause temporary or medically reversible health consequences, but the likelihood of serious harm is remote.
Cefazolin is an antibiotic used to prevent or treat serious bacterial infections.